Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 70/100Confidence medium
biorxiv2026-08-14immunologymetabolismredox biologyextracellular vesicles

Severe endometriosis lesion vesicles enter endothelial mitochondria and push angiogenesis

Small extracellular vesicles from endometriosis patients change with stage and source. Lesion-derived vesicles lose epithelial surface markers, gain immune signatures, and, when they come from severe disease, show enhanced uptake and mitochondrial localization in human uterine microvascular endothelial cells and promote angiogenesis. Plasma vesicles shift adhesion- and platelet-associated profiles. Multi-omics add coordinated immune, matrix, epithelial, vascular, oxidative-stress, and metabolic programs. The mitochondrial claim is trafficking-plus-function in endothelial cells, not a respiratory-chain map of the lesion.

Mito.news · at a glance

Signal profile (abstract-level)

immunology · metabolism · redox biology · extracellular vesicles

Score 70/100BIORXIVmedium confidenceimmunology
70
Importance
50
Mito signal
67
Dysfunction
75
Evidence
65
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Finding. Severe endometriosis packages a vesicle that uterine endothelial cells swallow and send to mitochondria, then the endothelium makes more vessels. Across eutopic endometrium, ectopic lesions, peritoneal fluid, and plasma, small extracellular vesicle composition tracks disease stage and source. Lesion vesicles shed epithelial markers and pick up immune signatures. Plasma vesicles look more adhesion- and platelet-like. Multi-omics add oxidative-stress and metabolic-adaptation programs. The organelle hook is destination and angiogenesis, not a lesion respirometry.

Why this paper matters

Endometriosis is common, inflammatory, and mechanistically still messy. Vesicles are an obvious way lesions talk to peritoneum and vessels. This paper’s contribution is stratification: stage and biofluid are not interchangeable, and the severe-lesion vesicle has a mitochondrial address in the endothelium that builds blood supply.

For a mitochondrial desk that is a trafficking paper. It earns a brief because mitochondrial localization is scored and tied to a function (angiogenesis), and because oxidative-stress/metabolic programs sit in the omics. It does not earn an OXPHOS score.

What they actually measured

sEVs from four sources × mild/severe/control. Surface markers, proteomics, lipidomics, integrated multi-omics. Functional assays on human uterine microvascular endothelial cells: uptake, mitochondrial localization, angiogenic activity. Severe-lesion sEVs win those last three.

Missing: n, isolation protocol, endothelial bioenergetics, in vivo vascularization. “Candidate biomarkers and therapeutic targets” is a closing sentence, not a locked assay.

How to read the score

Around 70. Real mitochondrial localization, weak mitochondrial mechanism. Confidence is medium. Score 70.

What to do with it

Track if you work on extracellular vesicles, endometriosis, or endothelial mitochondria. Pull the severe-lesion uptake/localization images and the multi-omics oxidative-stress module. Do not advertise a blood test. The directional implication is that late-stage lesion vesicles can enter endothelial mitochondria and push angiogenesis.

Free HTML is above. Bots pay for JSON at /api/v1/papers/10-64898-2026-08-13-744471. Optional wallet tester: MetaMask ($0.005).

Source preprint

Endometriosis patient-derived small extracellular vesicles carry unique immune, proteomic and lipidomic signatures associated with mild and severe endometriosis

10.64898/2026.08.13.744471

Holmes JP, Zutautas KB, Sisnett DJ, Hayati D, Bougie O, Lessey BA, Tayade C.

Related briefs